3,738
Views
3
CrossRef citations to date
0
Altmetric
Oncology

An indirect comparison between bosutinib, nilotinib and dasatinib in first-line chronic phase chronic myeloid leukemia

, ORCID Icon, , , &
Pages 801-809 | Received 13 Nov 2020, Accepted 24 Feb 2021, Published online: 02 Apr 2021

Keep up to date with the latest research on this topic with citation updates for this article.

Articles from other publishers (3)